Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6468675

COc1cc2c(C)nc(Nc3nc(O)c4cccc(F)c4n3)nc2c(OC)c1OC.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 1/20 0.38
BCHE P06276 2/20 0.35
APP P05067 1/20 0.35
MAOA P21397 1/20 0.35
ACHE P22303 1/20 0.35
MAOB P27338 1/20 0.35
KMT2A Q03164 1/20 0.35
HDAC6 Q9UBN7 1/20 0.34
POLB P06746 2/20 0.34
MAPT P10636 2/20 0.34
KRAS P01116 2/20 0.34
GAA P10253 1/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6467456 0.93 KMT2A (0.36) BCHEAPPMAOAACHEMAOB
Trifluoroacetic Acid SCHEMBL6467189 0.88 ABCG2 (0.41) KMT2APOLBMAPTGAAWHR1
Trifluoroacetic Acid SCHEMBL6470311 0.88 TACR3 (0.37) TACR3KMT2AHDAC6POLBMAPT
Trifluoroacetic Acid SCHEMBL6470355 0.87 KMT2A (0.35) TACR3KMT2AHDAC6POLBMAPT
Trifluoroacetic Acid SCHEMBL6469971 0.86 KMT2A (0.39) TACR3KMT2APOLBMAPTGAA
SCHEMBL6468680 0.85 CXCR6 (0.35) TACR3BCHEAPPMAOAACHE
Trifluoroacetic Acid SCHEMBL6468690 0.84 ADORA2A (0.38) KMT2APOLBGAAADORA2A
Trifluoroacetic Acid SCHEMBL6470323 0.82 POLB (0.37) KMT2APOLBGAAADORA2A
Trifluoroacetic Acid SCHEMBL6466274 0.82 KMT2A (0.39) KMT2APOLBMAPTGAAMAPK1
Trifluoroacetic Acid SCHEMBL6467058 0.82 TDP2 (0.44) KMT2APOLBMAPTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB TACR3 4538/4885BCHE 404/4885APP 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.